KeremOzerMD

Endocrinology • Round Rock, TX

Diabetes, Lipid Metabolism

MD Texas Diabetes & Endocrinology

Join to view full profile

Dr. Ozer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ozer's full profile

Already have an account?

Office
110 Deer Ridge Dr
Round Rock, TX 78681
Phone+1 512-458-8400

Fax+1 512-458-8593

Education & Training

Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2006 - 2009
Baylor College of MedicineResidency, Internal Medicine, 2003 - 2005
Istanbul University FomClass of 2002

Certifications & Licensure

MA State Medical License 2023 - 2026
TX State Medical License 2008 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

Diabetes Recognition Program National Committee for Quality Assurance, 2013-2016
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

A Study of LY2623091 in Participants With High Blood Pressure Start of enrollment: 2014 Aug 01
Completed
Phase 2
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
Completed
Phase 3

Publications & Presentations

PubMed

1 citations
Impact of Infusion Set Materials and Designs on the Subcutaneous Response in People With Diabetes: A Rapid Review of the Literature.
Kristoffer Hendel, Tobias Stumpe, Kerem Ozer
Journal of Diabetes Science and Technology. 2023-03-01
31 citations
Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis.
Anders L Carlson, Timothy Dilon Daniel, Andrea DeSantis, Serge Jabbour, Esra Karslioglu French
BMJ Open Diabetes Research & Care. 2022-01-01
18 citations
Fast Acting Insulin Aspart Compared with Insulin Aspart in the Medtronic 670G Hybrid Closed Loop System in Type 1 Diabetes: An Open Label Crossover Study.
Kerem Ozer, Alison M Cooper, Lily P Ahn, Cassidy R Waggonner, Thomas Blevins
Diabetes Technology & Therapeutics. 2021-03-22